While the COVID-19 pandemic has been associated with the onset of psychiatric disorders in adults, little is known about children and adolescents with obsessive compulsive disorder.
The pathology, diagnosis, and treatment of the complex disorder, trichotillomania, is reviewed.
This clinical review assessed the use of exposure and response prevention therapy for patients with obsessive-compulsive disorder during the COVID-19 pandemic.
This study examines whether pretreatment brain activation during cognitive control and reward processing is associated with treatment response to CBT in patients with OCD.
An assessment of the nonpharmacologic and pharmacologic therapies currently available and new pharmacotherapy options being investigated.
The socioeconomic character of a neighborhood, as well as accessibility of mental health care services, influence the wellbeing of patients with psychiatric disorders.
Mental health disturbances were found to be common in patients with homozygous familial hypercholesterolemia.
Riluzole was overall well tolerated and associated with nonsignificant but positive effects in multiple psychiatric disorders, including depression and obsessive-compulsive disorder.
In body dysmorphic disorder, the higher a patient’s readiness to change and confidence in cognitive behavioral therapy, the more likely the intervention will be successful.
Patients with obsessive-compulsive disorder and bipolar disorder are at greater risk for suicide.
